Resultados de la búsqueda 201-210 of 8585 for ibd

  1. Hematología - Ensayos clínicos - Mayo Clinic

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  3. Hematología - Ensayos clínicos - Mayo Clinic

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

  4. La salud de los niños Noticias de la Mayo Clinic - Mayo Clinic

    News · mayo 2025 · abril 2025 · enero 2025 · noviembre 2024 · octubre 2024 · septiembre 2024 · agosto 2024 · julio 2024.

  5. Radiología - Ensayos clínicos - Mayo Clinic

    The overall purpose is to study how a variety of technological approaches in Magnetic resonance imaging (MRI) can be used to provide improved performance non- ...

  6. ¿Es más saludable consumir jugos que comer las frutas o los vegetales enteros?

    IBD overview. American College of Gastroenterology. https://gi.org/topics/inflammatory-bowel-disease/#tabs2. Accessed June 19, 2023. Low-fiber foods ...

  7. Oncología (médica) - Ensayos clínicos

    For example, inflammatory bowel disease is a major predisposing factor for colorectal cancer occurrence, implicating inflammation in the development of ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to assess the presence of various molecular markers in histiocytic disorders. In addition to this, to review ...

  9. Estar en forma - Mayo Clinic

    News. 2025. Mayo Clinic Q and A: Water fitness -- why aqua exercise works wonders July 25, 2025, 01:45 p.m. CDT · Mayo Clinic Q&A: Why you should know your ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...